However, in the context of chronic systemic inflammation, as seen in obesity, IL-6 predominantly engages in trans-signaling via its soluble receptor (sIL-6R), promoting catabolic and inflammatory effects in joint tissues. Here, IL6 is linked to obesity due to melanocortin 4 receptor deficiency.